Our laboratory has been particularly interested in this latter phenomenon, as CD8+ T cell responses to well-established B16 melanoma have been shown to exhibit the type of dysfunction often associated with anti-tumor T cell responses in melanoma patients (9–12). Here, CD8A is linked to melanoma.